down arrow

Yili Chuannig Biotechnology Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005WX0
CNY
10.15
0.03 (0.3%)

Dec 19

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Yili Chuannig Biotechnology Co., Ltd.
Why is Yili Chuannig Biotechnology Co., Ltd. ?
1
With a fall in Net Sales of -37.19%, the company declared Very Negative results in Mar 25
  • NET SALES(Q) Fallen at -15.17%
  • OPERATING PROFIT(Q) Lowest at CNY 355.12 MM
  • OPERATING PROFIT MARGIN(Q) Lowest at 27.84 %
2
Below par performance in long term as well as near term
  • Along with generating -25.74% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Yili Chuannig Biotechnology Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Yili Chuannig Biotechnology Co., Ltd.
-18.99%
-0.35
38.03%
China Shanghai Composite
15.44%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
10.81%
EBIT Growth (5y)
54.71%
EBIT to Interest (avg)
85.34
Debt to EBITDA (avg)
0.69
Net Debt to Equity (avg)
-0.01
Sales to Capital Employed (avg)
0.55
Tax Ratio
16.66%
Dividend Payout Ratio
42.88%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7,093.73%
ROE (avg)
3,839.06%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
0.87
EV to EBIT
5.04
EV to EBITDA
3.54
EV to Capital Employed
0.87
EV to Sales
1.43
PEG Ratio
NA
Dividend Yield
2.44%
ROCE (Latest)
17.30%
ROE (Latest)
14.01%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 1,637.7 MM

DEBT-EQUITY RATIO (HY)

Lowest at 5.05 %

RAW MATERIAL COST(Y)

Fallen by -10.56% (YoY

-6What is not working for the Company
NET SALES(Q)

Fallen at -15.17%

OPERATING PROFIT(Q)

Lowest at CNY 355.12 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 27.84 %

PRE-TAX PROFIT(Q)

Lowest at CNY 350.66 MM

NET PROFIT(Q)

Lowest at CNY 288.22 MM

EPS(Q)

Lowest at CNY 0.13

Here's what is working for Yili Chuannig Biotechnology Co., Ltd.
Operating Cash Flow
Highest at CNY 1,637.7 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Debt-Equity Ratio
Lowest at 5.05 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -10.56% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Yili Chuannig Biotechnology Co., Ltd.
Net Sales
Fallen at -15.17%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit
Lowest at CNY 355.12 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 27.84 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at CNY 350.66 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit
Lowest at CNY 288.22 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS
Lowest at CNY 0.13
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."